$300 Million Settlement proposed for people suffering side effects from Benicar®, Benicar HCT®, Azor®, or Tribenzor®.
A proposed settlement of $300 million has been set up for people who suffered gastrointestinal problems or kidney failure after taking high blood pressure medications with the active ingredient olmesartan medoxomil including Benicar®, Benicar HCT®, Azor® and Tribenzor®. Under the specific terms of the settlement, only people who started taking one of these drugs before May 1, 2015 and have signed a retainer agreement with an attorney by the end of the day on August 23, 2017 will have an opportunity to take part in the settlement.
Olmesartan Medoxomil And Chronic Diarrhea
The most common side effect of these high blood pressure drugs is chronic diarrhea. Chronic diarrhea can in turn lead to dehydration, electrolyte imbalance, and malnutrition due to the body’s inability to absorb nutrients. The long-term effects of these conditions include fatigue, dizziness, drowsiness, and confusion. Left untreated, these long-term effects can be life-threatening.
Other side effects of Benicar®, Benicar HCT®, Azor® and Tribenzor®
There are a number of side effects associated with medications containing Olmesartan Medoxomil that can lead to substantial weight loss and hospitalization.
These side effects include:
• Sprue-like Symptoms
• Celiac-like Symptoms
• Substantial Weight Loss
• Villous Atrophy
If you or a loved started taking Benicar®, Benicar HCT®, Azor® or Tribenzor® before May 1, 2015 and were hospitalized for any of the conditions listed above, you may qualify for part of the settlement. However, the deadline for filing a claim is August 23, 2017, so you must act now. Only people who sign a retainer agreement with a law firm before the end of the day on August 23, 2017 will be eligible to take part in the $300 million settlement. Call the Gold Shield Group now at 800-568-9412.